Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

HPV Infection in Cervical and Other Cancers in Saudi Arabia: Implication for Prevention and Vaccination.

Alsbeih G.

Front Oncol. 2014 Mar 31;4:65. doi: 10.3389/fonc.2014.00065. eCollection 2014. Review.

2.

The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management.

Brinkman JA, Caffrey AS, Muderspach LI, Roman LD, Kast WM.

Eur J Gynaecol Oncol. 2005;26(2):129-42. Review.

PMID:
15857016
3.

Cost-effectiveness analysis of a quadrivalent human papilloma virus vaccine in Mexico.

Reynales-Shigematsu LM, Rodrigues ER, Lazcano-Ponce E.

Arch Med Res. 2009 Aug;40(6):503-13. doi: 10.1016/j.arcmed.2009.08.004.

PMID:
19853192
4.

Anal dysplasia screening: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2007;7(4):1-43. Epub 2007 Jun 1.

5.

Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.

Rogovskaya SI, Shabalova IP, Mikheeva IV, Minkina GN, Podzolkova NM, Shipulina OY, Sultanov SN, Kosenko IA, Brotons M, Buttmann N, Dartell M, Arbyn M, Syrjänen S, Poljak M.

Vaccine. 2013 Dec 31;31 Suppl 7:H46-58. doi: 10.1016/j.vaccine.2013.06.043.

PMID:
24332297
6.

Human papillomavirus prevalence and type distribution among women attending routine gynecological examinations in Saudi Arabia.

AlObaid A, Al-Badawi IA, Al-Kadri H, Gopala K, Kandeil W, Quint W, Al-Aker M, DeAntonio R.

BMC Infect Dis. 2014 Dec 14;14:643. doi: 10.1186/s12879-014-0643-8.

8.

Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.

Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE.

J Natl Cancer Inst. 2009 Apr 1;101(7):475-87. doi: 10.1093/jnci/djn510. Epub 2009 Mar 24.

9.

The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.

C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J.

Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230.

10.

Human papillomavirus infection and the primary and secondary prevention of cervical cancer.

Lowy DR, Solomon D, Hildesheim A, Schiller JT, Schiffman M.

Cancer. 2008 Oct 1;113(7 Suppl):1980-93. doi: 10.1002/cncr.23704. Review.

11.

Cancers attributable to human papillomavirus infection.

Grulich AE, Jin F, Conway EL, Stein AN, Hocking J.

Sex Health. 2010 Sep;7(3):244-52. doi: 10.1071/SH10020.

PMID:
20719211
12.

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24.

13.

[Cervical cancer prevention: the impact of HPV vaccination].

Monsonégo J.

Gynecol Obstet Fertil. 2006 Mar;34(3):189-201. Epub 2006 Mar 10. Review. French.

PMID:
16529969
14.

Prophylactic HPV vaccination: past, present, and future.

Castle PE, Maza M.

Epidemiol Infect. 2016 Feb;144(3):449-68. doi: 10.1017/S0950268815002198. Epub 2015 Oct 2. Review.

PMID:
26429676
15.

Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors.

Damm O, Nocon M, Roll S, Vauth C, Willich S, Greiner W.

GMS Health Technol Assess. 2009 Mar 11;5:Doc04. doi: 10.3205/hta000066.

16.

Current studies on human papillomavirus in Saudi Arabia.

Alhamlan FS, Al-Qahtani AA, Al-Ahdal MN.

J Infect Dev Ctries. 2015 Jul 4;9(6):571-6. doi: 10.3855/jidc.6538. Review.

17.

Prevalence and molecular epidemiology of human papillomavirus infection in italian women with cervical cytological abnormalities.

Meloni A, Pilia R, Campagna M, Usai A, Masia G, Caredda V, Coppola RC.

J Public Health Res. 2014 Mar 26;3(1):157. doi: 10.4081/jphr.2014.157. eCollection 2014 Mar 26.

18.

Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.

Poljak M, Seme K, Maver PJ, Kocjan BJ, Cuschieri KS, Rogovskaya SI, Arbyn M, Syrjänen S.

Vaccine. 2013 Dec 31;31 Suppl 7:H59-70. doi: 10.1016/j.vaccine.2013.03.029. Review.

PMID:
24332298
19.

[Prevention of cervical cancer (II): prophylactic HPV vaccination, current knowledge, practical procedures and new issues].

Monsonego J.

Presse Med. 2007 Apr;36(4 Pt 2):640-66. Epub 2007 Mar 12. Review. French. Erratum in: Presse Med. 2007 Jul-Aug;36(7-8):1150-1.

PMID:
17350792
20.

Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies.

Tota JE, Chevarie-Davis M, Richardson LA, Devries M, Franco EL.

Prev Med. 2011 Oct;53 Suppl 1:S12-21. doi: 10.1016/j.ypmed.2011.08.017. Review.

PMID:
21962466

Supplemental Content

Support Center